Since the establishment of the Global Fund in 2002, various organisations have been formed as “Friends of the Fund.” They promote the work of the Fund and mobilise financial and political support for it.
The future of the Affordable Medicines Facility–malaria (AMFm) will be decided at the Global Fund Board meeting on 14–15 November 2012. The outcome appears anything but certain. The AMFm was launched as a two-year pilot phase in April 2009 and began operations in July 2010. The AMFm is hosted by the Global Fund but its programme funding comes from other donors.
The Global Fund Board recently approved two Round 8 malaria grant renewals for Nigeria worth $225 million. This amount included $50 million in “new” money, which will be used to purchase bed nets.
In June 2012, the Global Fund Board approved the “re-launch” of a health systems strengthening (HSS) grant in Mozambique. After two years of inactivity, the grant was re-launched as a three-year re-programmed grant. It is believed to be the first time a grant has ever been re-launched.
A new publication from Aidspan, by Dr David McCoy, reviews a published academic study on the impact of Global Fund grants for malaria prevention.
The Global Fund has brokered debt swap agreement before, but not like the latest one between Germany and Egypt.
According to data compiled by the Global Fund, since the introduction of the Affordable Medicines Facility-malaria (AMFm) programme, the average cost of a course of artemisinin combination therapy (ACT) in private pharmacies has dropped by about 90% in parts of Kenya and by about 40% to 90% in Ghana, the first two countries to participate in the programme.
Malaria patients in eight countries in sub-Saharan Africa and Asia will pay significantly less for ACTs (artemisinin-based combination therapies) purchased through the private health care system, as a result of agreements between the Global Fund and six manufacturers of malaria drugs.
The Global Fund plans to monitor and publicise cases where funding proposals have been, or might be, rejected due to policy environments where human rights violations are impeding the implementation or impact of interventions against AIDS, TB and malaria. This is one of the highlights of the Global Fund's policy and implementation plan on Sexual Orientation and Gender Identity (SO
The Global Fund Board's delegation of Communities Living with HIV, TB and affected by malaria is looking for people willing to be part of the delegation for a three-year period, from 2011 through 2013.